New study tests faster brain zaps for stubborn depression

NCT ID NCT07264452

First seen Jan 03, 2026 · Last updated Jun 19, 2026 · Updated 24 times

Summary

This study compares two accelerated forms of transcranial magnetic stimulation (TMS) for people with treatment-resistant depression. 60 participants will receive either intermittent or continuous theta burst stimulation over two weeks, with a 12-week follow-up. The goal is to see which type better reduces depression, anxiety, and suicidal thoughts.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ataturk University

    RECRUITING

    Erzurum, 25240, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Transcranial magnetic stimulation (TMS) using a figure-eight coil

What this could lead to

If successful, this could identify a more effective TMS protocol for people with depression that hasn't responded to medication.

What could go wrong

This is a small, early-stage study with only 60 participants. The results may not apply to everyone, and the benefits might not last beyond the 12-week follow-up.

Conditions

The condition(s) this trial relates to.

Depressive Disorder, Treatment-Resistant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.